Related Experiment Video
Updated: Aug 26, 2026

Peptide-derived Method to Transport Genes and Proteins Across Cellular and Organellar Barriers in Plants
Published on: December 16, 2016
Posttranslational modification of therapeutic proteins in plants
1CNRS UMR 6037-IFRMP 23-GDR 2590, Université de Rouen-Bâtiment de Biologie (extension), Blvd de Broglie, 76821 Mont Saint Aignan Cedex, France. vgomord@crihan.fr
Abstract:
Plants have emerged as an alternative to current systems for the production of therapeutic proteins. The advantages of plants for the low-cost and large-scale production of safe and biologically active mammalian proteins have been documented recently. A major advantage of transgenic plants over production systems that are based on yeast or Escherichia coli is their ability to perform most of the posttranslational modifications (PTMs) that are required for the bioactivity and pharmacokinetics of recombinant therapeutic proteins. Furthermore, recent advances in the control of PTMs in transgenic plants have made it possible for plants to perform, at least to some extent, human-like modifications of recombinant proteins. Hence, plants have become a suitable alternative to animal cell factories for the production of therapeutic proteins.
Related Concept Videos
Transgenic Plants
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
Production of Pharmaceuticals
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Upstream Processing
Regulation of Expression at Multiple Steps
What is Gene Expression?

